SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Exelixis, Inc. (EXEL)
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
930 66 0 EXEL
Emcee:  kinkblot Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
430XL795 (PI3K+) P1 oral presentation at asco.keokalani'nui-4/21/2008
429Slough, UK, 15 April 2008 – Piramed Limited (Piramed), a privately owned UK biotkeokalani'nui-4/21/2008
428in the past year, days where volume was > 2 million..... 14 March (3.0m, thrscaram(o)uche-3/14/2008
427Option to Develop Exelixis Compound Exercised By Genentech Friday March 14, 6:00mopgcw-3/14/2008
42610-K is out..... <i>We currently have various compounds in preclinical descaram(o)uche-2/25/2008
425Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results Thursday mopgcw-2/14/2008
424x139 was described in 12/07 as "IND Ready" along with 2 other cpds in keokalani'nui-1/22/2008
423Exelixis and Bristol-Myers Squibb to Co-Develop XL139, an Inhibitor of the HedgeIcebrg-1/22/2008
422guffaw. thanks.scaram(o)uche-1/18/2008
421That would be Glaxo, but Roche probably doesn't, either. Cheers, Tucktuck-1/18/2008
420Roche (nor Glaxo, Tuck..... :-) doesn't want 784. Duh.scaram(o)uche-1/18/2008
419If you have to spend 3 whole days at the conference, you would be wooden too. Ikenhott-1/14/2008
418LOL, he sure can, and she was indeed wooden.tom pope-1/13/2008
417Scangos caught on video by a newsreporter, who doesn't seem overly interesteIcebrg-1/13/2008
416Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lungkenhott-1/7/2008
415Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb Thursday DecembeIcebrg-12/20/2007
414GlaxoSmithKline, Via Its Center of Excellence for External Drug Discovery, Exercidos-12/14/2007
413Oh, right, that's a repeat news item . . . so EXEL's remaining sttuck-12/13/2007
412Message 24071407 $20M.scaram(o)uche-12/13/2007
411CRL & Jackson Labs competitor Taconic buys most of EXEL's Artemis, but ttuck-12/11/2007
410What's another 1.2M shares to pass out to the top 7 people when you dilute arkrw-12/11/2007
409morning star: Thesis 10-31-2007 Exelixis has a talent for discovering promisimopgcw-12/11/2007
408The current pecking order at EXEL has been established through the recent rewardIcebrg-12/10/2007
407<<Incy has a hot jak2 inh that is ahead, also reporting as ASH. Not sure keokalani'nui-12/10/2007
406Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement Icebrg-11/29/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News